Patents by Inventor James Coe
James Coe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20250115533Abstract: Gas-liquid separation comprising a) feeding a product stream comprising a mixture of liquid and gaseous hydrocarbon products and water vapour; b) collecting the first liquid at a liquid outlet of the first vapour-liquid separator; c) discharging the first gas stream from a gas outlet of the first vapour-liquid separator; d) feeding the first cooled mixture from the first cooler into a second vapour-liquid separator; e) collecting the second liquid at a liquid outlet of the second vapour-liquid separator; f) discharging the second gas stream from a gas outlet of the second vapour-liquid separator; g) feeding the second gas stream from the gas outlet of the second vapour-liquid separator through a second cooler; h) feeding the second cooled mixture from the second cooler into a third vapour-liquid separator; i) collecting the third liquid at a liquid outlet; and j) discharging the third gas stream from a gas outlet.Type: ApplicationFiled: February 15, 2023Publication date: April 10, 2025Inventors: Roger Kenneth BENCE, Jay Simon CLARKSON, Andrew James COE
-
Patent number: 12268471Abstract: Disclosed are systems and methods utilizing an infrared probe and discriminating software to rapidly discriminate abnormal tissue processes from normal tissue during surgery, physical examination of in-situ lesions, and in the assessment of biopsy and resected tissue specimens. Examples demonstrate discrimination of cancerous from noncancerous tissues. The discriminating software, i.e. the metrics, algorithms, calibrant spectra, and decision equations, allows tissue to be identified as abnormal or normal using a minimum of infrared (IR) wavelengths in order to be measured rapidly. The probe records IR metrics approximately 1000 times faster than current commercial instruments, i.e. on a timescale fast enough for clinical use. The probe uses a tunable mid-infrared laser with a small set of selected wavelengths that are optimized for detecting the chemical and molecular signatures of tissue specific lesions to include, but not limited to, cancer, preneoplasia, intracellular accumulations (e.g.Type: GrantFiled: April 18, 2024Date of Patent: April 8, 2025Assignee: Ohio State Innovation FoundationInventors: James Coe, Heather Allen, Charles Hitchcock, Edward W. Martin
-
Publication number: 20250100875Abstract: A method of forming a syngas for producing liquid hydrocarbons, the method comprising: providing a feed gas comprising carbon dioxide, hydrogen and compounds of sulfur; providing a carbon-monoxide-enriched feed gas by passing the feed gas to a reverse-water-gas-shift reaction chamber to convert a portion of the carbon dioxide and a portion of the hydrogen to carbon monoxide and water, and to convert at least a portion of the compounds of sulfur to hydrogen sulfide; passing the carbon-monoxide-enriched feed gas to a carbon-dioxide-removal unit to provide the syngas and a carbon-dioxide-enriched stream, the carbon-dioxide-enriched stream comprising carbon dioxide and hydrogen sulfide; providing a purified carbon-dioxide stream by passing the carbon-dioxide-enriched stream to a hydrogen-sulfide-removal unit to remove hydrogen sulfide from the carbon-dioxide-enriched stream; and recycling the purified carbon-dioxide stream into the feed gas.Type: ApplicationFiled: March 16, 2023Publication date: March 27, 2025Inventors: Stuart William ALLAN, Andrew James COE, Amelia Lorna Solveig COOK, Cuijie JIANG, Raul LLORENS NAVARRO, Michiel NIJEMEISLAND, Jon-Pierre SUNDERLAND
-
Publication number: 20250100949Abstract: The present disclosure relates generally to processes for initiating Fischer-Tropsch synthesis. In particular, the application concerns a process for the initiation of Fischer-Tropsch synthesis, the process comprising: (i) providing the reaction zone with a temperature of no more than 140° C.; then (ii) purging the reaction zone with a purge gas comprising N2 at a pressure in the range of 2 barg to 10 barg; then (iii) contacting the catalyst in the reaction zone with a gaseous reaction mixture comprising H2 and CO in a ratio of between 1:1 and 3:1 at a pressure of no more than 20 barg and at a temperature of no more than 140° C.; then (iv) heating the reaction zone to a temperature of at least 200° C.; and (v) pressurizing the reaction zone to a pressure in the range of 30 barg and 45 barg.Type: ApplicationFiled: December 22, 2022Publication date: March 27, 2025Inventors: Alexander James Paterson, Jay Simon Clarkson, Andrew James Coe
-
Publication number: 20250059110Abstract: The present disclosure relates generally to processes for activating Fischer-Tropsch synthesis catalysts. In particular, the application concerns a process for the activation of a Fischer-Tropsch synthesis catalyst, the process comprising: (i) contacting the catalyst with a first gaseous composition comprising at least 80% N2 at a pressure in the range of 2 barg to 20 barg at a temperature of no more than 150° C.; (ii) contacting the catalyst with a second gaseous composition comprising at least 80% H2 to form a H2/N2 gaseous composition with a H2:N2 molar ratio in the range of 0.2:1 to 2:1, resulting in a pressure in the range of 10 barg to 30 barg; (iii) increasing the temperature to a range of 220° C. to 260° C.; (iv) maintaining the catalyst at the conditions of step (iii) for a hold period in the range of 2 hr to 96 hr.Type: ApplicationFiled: December 22, 2022Publication date: February 20, 2025Inventors: Alexander James Paterson, Jay Simon Clarkson, Andrew James Coe, Richard John Mercer, John West, Robert Miles Baker
-
Publication number: 20250017470Abstract: Disclosed are systems and methods utilizing an infrared probe and discriminating software to rapidly discriminate abnormal tissue processes from normal tissue during surgery, physical examination of in-situ lesions, and in the assessment of biopsy and resected tissue specimens. Examples demonstrate discrimination of cancerous from noncancerous tissues. The discriminating software, i.e. the metrics, algorithms, calibrant spectra, and decision equations, allows tissue to be identified as abnormal or normal using a minimum of infrared (IR) wavelengths in order to be measured rapidly. The probe records IR metrics approximately 1000 times faster than current commercial instruments, i.e. on a timescale fast enough for clinical use. The probe uses a tunable mid-infrared laser with a small set of selected wavelengths that are optimized for detecting the chemical and molecular signatures of tissue specific lesions to include, but not limited to, cancer, preneoplasia, intracellular accumulations (e.g.Type: ApplicationFiled: April 18, 2024Publication date: January 16, 2025Inventors: James COE, Heather ALLEN, Charles HITCHCOCK, Edward W. MARTIN
-
Publication number: 20240367373Abstract: Aspects disclosed herein related to a method of manufacturing a beverage pod that comprise loading successive layers of a beverage material, such as coffee, onto a print bed of a three-dimensional (3-D) printer. A binder is then applied to each of the successive layers of beverage material in a predetermined pattern to bond the beverage material in the predetermined pattern. The predetermined pattern corresponds to a sequential cross-sectional layer of an object model of the beverage pod where the object model describes sequential cross-sectional layers of the beverage pod designed based on a plurality of different brewing attributes.Type: ApplicationFiled: May 1, 2024Publication date: November 7, 2024Applicant: Keurig Green Mountain, Inc.Inventor: Francis James Coe
-
Patent number: 11986268Abstract: Disclosed are systems and methods utilizing an infrared probe and discriminating software to rapidly discriminate abnormal tissue processes from normal tissue during surgery, physical examination of in-situ lesions, and in the assessment of biopsy and resected tissue specimens. Examples demonstrate discrimination of cancerous from noncancerous tissues. The discriminating software, i.e. the metrics, algorithms, calibrant spectra, and decision equations, allows tissue to be identified as abnormal or normal using a minimum of infrared (IR) wavelengths in order to be measured rapidly. The probe records IR metrics approximately 1000 times faster than current commercial instruments, i.e. on a timescale fast enough for clinical use. The probe uses a tunable mid-infrared laser with a small set of selected wavelengths that are optimized for detecting the chemical and molecular signatures of tissue specific lesions to include, but not limited to, cancer, preneoplasia, intracellular accumulations (e.g.Type: GrantFiled: April 26, 2023Date of Patent: May 21, 2024Assignee: OHIO STATE INNOVATION FOUNDATIONInventors: James Coe, Heather Allen, Charles Hitchcock, Edward W. Martin
-
Publication number: 20230357101Abstract: A method is described for shutting down a Fischer-Tropsch reactor fed with a reactant gas mixture comprising a synthesis gas and a recycle gas recovered from the Fischer-Tropsch reactor in a synthesis loop, said Fischer-Tropsch reactor containing a Fischer-Tropsch catalyst cooled indirectly by a coolant under pressure, comprising the steps of: (a) depressurising the coolant to cool the reactant gas mixture to quench Fischer-Tropsch reactions taking place in the Fischer-Tropsch reactor, (b) stopping the synthesis gas feed to the Fischer-Tropsch reactor, and (c) maintaining circulation of the recycle gas through the Fischer-Tropsch reactor during steps (a) and (b) to remove heat from the Fischer-Tropsch reactor. The method safely facilitates a more rapid return to operating conditions than a full shut-down.Type: ApplicationFiled: November 12, 2021Publication date: November 9, 2023Inventors: Robert Miles BAKER, Jay Simon CLARKSON, Andrew James COE, Robert William GALLEN, Richard Philip David PEARSON, Colin TAMSETT
-
Publication number: 20230346223Abstract: Disclosed are systems and methods utilizing an infrared probe and discriminating software to rapidly discriminate abnormal tissue processes from normal tissue during surgery, physical examination of in-situ lesions, and in the assessment of biopsy and resected tissue specimens. Examples demonstrate discrimination of cancerous from noncancerous tissues. The discriminating software, i.e. the metrics, algorithms, calibrant spectra, and decision equations, allows tissue to be identified as abnormal or normal using a minimum of infrared (IR) wavelengths in order to be measured rapidly. The probe records IR metrics approximately 1000 times faster than current commercial instruments, i.e. on a timescale fast enough for clinical use. The probe uses a tunable mid-infrared laser with a small set of selected wavelengths that are optimized for detecting the chemical and molecular signatures of tissue specific lesions to include, but not limited to, cancer, preneoplasia, intracellular accumulations (e.g.Type: ApplicationFiled: April 26, 2023Publication date: November 2, 2023Inventors: James COE, Heather ALLEN, Charles HITCHCOCK, Edward W. MARTIN
-
Publication number: 20230295517Abstract: A process for synthesising hydrocarbons is described comprising the steps of (a) making a synthesis gas comprising hydrogen, carbon monoxide and carbon dioxide from a feedstock in a synthesis gas generation unit, (b) removing carbon dioxide to produce a carbon dioxide stream and purified synthesis gas comprising hydrogen and carbon monoxide for synthesis gas in a Fischer-Tropsch hydrocarbon synthesis unit wherein (i) at least a portion of the FT water stream is fed to an electrolysis unit to provide an oxygen stream, which is fed to the synthesis gas generation unit. Carbon dioxide stream recovered from the carbon dioxide removal unit and a portion of the hydrogen stream produced by the electrolysis unit are fed to a reverse water-gas shift unit to produce a carbon monoxide stream, with carbon monoxide stream from the reverse water-gas shift unit fed to the Fischer-Tropsch hydrocarbon synthesis unit.Type: ApplicationFiled: September 17, 2021Publication date: September 21, 2023Inventors: Henry Arthur CLAXTON, Andrew James COE, Mark Joseph MCKENNA, Paul Robert TICEHURST
-
Patent number: 11678802Abstract: Systems and methods utilize an infrared probe and discriminating software to rapidly discriminate normal tissue processes from normal tissue during surgery, physical examination of in-situ lesions, and in the assessment of biopsy and resected tissue specimens. Examples demonstrate discrimination of cancerous from noncancerous tissues. The discriminating software, i.e. the metrics, algorithms, calibrant spectra, and decision equations, allows tissue to be identified as abnormal or normal using a minimum of infrared (IR) wavelengths in order to be measured rapidly. The probe records IR metrics approximately 1000 times faster than current commercial instruments, i.e. on a timescale fast enough for clinical use. The probe uses a tunable mid-infrared laser with a small set of selected wavelengths that are optimized for detecting the chemical and molecular signatures of tissue specific lesions to include, but not limited to, cancer, preneoplasia, intracellular accumulations (e.g.Type: GrantFiled: March 16, 2017Date of Patent: June 20, 2023Assignee: OHIO STATE INNOVATION FOUNDATIONInventors: James Coe, Heather Allen, Charles Hitchcock, Edward W. Martin
-
Patent number: 11540722Abstract: An etalon-based mid-infrared probe can be configured for spectroscopic tissue discrimination, such as between non-normal (e.g., cancerous) and normal (e.g., healthy) tissue. A broadband light source can be applied to the etalon to generate fringes at spectroscopic wavelengths of interest, which can be delivered to a tissue specimen via a fiber loop probe. A response signal can be spectral dispersed across a parallel array of detector pixels, such as using a diffraction grating, and signal processed for performing the tissue classification. A learning model can be trained, using full IR spectral data, for applying a reduced set of wavelengths for performing the spectroscopic tissue analysis and classification.Type: GrantFiled: April 8, 2022Date of Patent: January 3, 2023Assignee: Ohio State Innovation FoundationInventor: James Coe
-
Publication number: 20220322947Abstract: An etalon-based mid-infrared probe can be configured for spectroscopic tissue discrimination, such as between non-normal (e.g., cancerous) and normal (e.g., healthy) tissue. A broadband light source can be applied to the etalon to generate fringes at spectroscopic wavelengths of interest, which can be delivered to a tissue specimen via a fiber loop probe. A response signal can be spectral dispersed across a parallel array of detector pixels, such as using a diffraction grating, and signal processed for performing the tissue classification. A learning model can be trained, using full IR spectral data, for applying a reduced set of wavelengths for performing the spectroscopic tissue analysis and classification.Type: ApplicationFiled: April 8, 2022Publication date: October 13, 2022Inventor: James Coe
-
Publication number: 20190110687Abstract: Disclosed are systems and methods utilizing an infrared probe and discriminating software to rapidly discriminate normal tissue processes from normal tissue during surgery, physical examination of in-situ lesions, and in the assessment of biopsy and resected tissue specimens. Examples demonstrate discrimination of cancerous from noncancerous tissues. The discriminating software, i.e. the metrics, algorithms, calibrant spectra, and decision equations, allows tissue to be identified as abnormal or normal using a minimum of infrared (IR) wavelengths in order to be measured rapidly. The probe records IR metrics approximately 1000 times faster than current commercial instruments, i.e. on a timescale fast enough for clinical use. The probe uses a tunable mid-infrared laser with a small set of selected wavelengths that are optimized for detecting the chemical and molecular signatures of tissue specific lesions to include, but not limited to, cancer, preneoplasia, intracellular accumulations (e.g.Type: ApplicationFiled: March 16, 2017Publication date: April 18, 2019Applicant: Ohio State Innovation FoundationInventors: James COE, Heather ALLEN, Charles HITCHCOCK, Edward W. MARTIN
-
Patent number: 9935478Abstract: A power delivery rate from a renewable power source to a load is managed by determining, by processing circuitry, a change in a power generation rate, determining, by the processing circuitry, whether the change in the power generation rate exceeds a limit, and then, adjusting, by control circuitry, a power transfer rate to or from a power storage device, such that the adjusting is sufficient to prevent the power delivery rate from exceeding the limit.Type: GrantFiled: November 3, 2015Date of Patent: April 3, 2018Assignee: YOUNICOS, INC.Inventors: Carlos James Coe, Aeron Neils Hurst, Mark Isaac Hardin, Matthew Clayton Such, Richard Thomas Jennings
-
Patent number: 9702992Abstract: In one aspect, an apparatus is disclosed comprising: a housing; a proof mass movable within the housing; an optical element mounted on one of the housing and the proof mass; a reflective element on the other one of the housing and the proof mass; a light source configured to illuminate grating and minor; and one or more detectors configured to detect light incident from the reflective element and the diffractive element and generate a signal indicative of the relative displacement of proof mass and the housing.Type: GrantFiled: March 15, 2013Date of Patent: July 11, 2017Assignee: SILICON AUDIO SEISMIC, LLCInventors: Bradley Dean Avenson, Matthew Raymon Christensen, Caesar Theodore Garcia, Neal Allen Hall, Abidin Guclu Onaran, James Coe Schlicher, Ahmad Zaatari
-
Patent number: D812250Type: GrantFiled: March 15, 2017Date of Patent: March 6, 2018Inventor: James Coe
-
Patent number: D836800Type: GrantFiled: March 15, 2017Date of Patent: December 25, 2018Inventor: James Coe
-
Patent number: D846154Type: GrantFiled: March 15, 2017Date of Patent: April 16, 2019Inventor: James Coe